34
Participants
Start Date
December 31, 2016
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2027
Busulfan
intravenous, 3.2 mg/kg + 5% DW (the diluent quantity should be 10 times the volume of Busulfan, so that the final concentration of busulfan becomes approximately 0.5 mg/mL), once daily for 3 hours for 3 days (days -7 to -5)
Fludarabine
intravenous, 30 mg/m2 + 5% DW 100㎖, over 1 hour once daily for 6 days (days -8 to -3)
RECRUITING
Dong-A University, Busan
RECRUITING
Keimyung University Dongsan Medical Center, Daegu
Collaborators (1)
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
Keimyung University Dongsan Medical Center
OTHER